pargyline has been researched along with Mental Disorders in 4 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Mental Disorders: Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| SAUNDERS, JC | 1 |
| SHARPLEY, P | 1 |
| MENA, A | 1 |
| SCHIELE, BC | 1 |
| HEISTAD, G | 1 |
| MCCURDY, RL | 1 |
| KAN, FJ | 1 |
| Keck, PE | 1 |
| Vuckovic, A | 1 |
| Pope, HG | 1 |
| Nierenberg, AA | 1 |
| Gribble, GW | 1 |
| White, K | 1 |
1 trial available for pargyline and Mental Disorders
| Article | Year |
|---|---|
Acute cardiovascular response to monoamine oxidase inhibitors: a prospective assessment.
Topics: Agoraphobia; Blood Pressure; Bulimia; Depressive Disorder; Humans; Mental Disorders; Monoamine Oxida | 1989 |
3 other studies available for pargyline and Mental Disorders
| Article | Year |
|---|---|
Treatment of hospitalized depressed and schizophrenic patients with monoamine oxidase inhibitors: including reflections on pargyline.
Topics: Humans; Mental Disorders; Monoamine Oxidase Inhibitors; Pargyline; Schizophrenia | 1963 |
A COMPARISON OF PARGYLINE AND TRANYLCYPROMINE WITH AND WITHOUT THE ADDITION OF TRIFLUOPERAZINE: A DOUBLE-BLIND STUDY.
Topics: Biomedical Research; Brain; Brain Damage, Chronic; Depressive Disorder, Major; Double-Blind Method; | 1964 |
TRANSIENT BRAIN SYNDROME AS A NON-FATAL REACTION TO COMBINED PARGYLINE-IMIPRAMINE TREATMENT.
Topics: Brain; Depression; Depressive Disorder; Drug Therapy; Geriatrics; Hypertension; Imipramine; Mental D | 1964 |